AngioSoma, Inc. (OTC: SOAN) Reports Esther & Esther Confident in New Revenue Plan

HOUSTON, TX (Marketwiredon September 21, 2017) – AngioSoma, Inc. (OTC: SOAN) — Esther & Esther management has high optimism that its revenue plan could prove successful.  The publicly stated plan simply and efficiently drives high volume traffic and interested buyers directly to EstherandEsther.com. As noted in the previous press release (which can be read here), Read more about AngioSoma, Inc. (OTC: SOAN) Reports Esther & Esther Confident in New Revenue Plan[…]

AngioSoma, Inc. (OTC: SOAN) Announces Agreement with Esther & Esther, Inc. to Maximize Sales of Its OTC Products with Existing Online Marketing Platform

Houston, TX, September 18, 2017 (PR.com) – AngioSoma, Inc. (OTC: SOAN) announces Agreement with Esther & Esther, Inc. to maximize sales of its OTC products with existing online marketing platform. Conjunctionally, the company’s subsidiary, Soma Nutraceuticals Inc., completed a licensing agreement with Kentucky-based East Kentucky Organic, Inc. to begin manufacturing of Soma Nutraceutical’s product line, Read more about AngioSoma, Inc. (OTC: SOAN) Announces Agreement with Esther & Esther, Inc. to Maximize Sales of Its OTC Products with Existing Online Marketing Platform[…]

Angiosoma.com-product - ticker SOAN OTC

AngioSoma, Inc. enters discussions with Nutraceutical Intellectual Property Owners

Montgomery, Texas (September 21, 2016) – AngioSoma, Inc. (the ‘Company‘, ‘we‘, and ‘our‘), announces the formation of the Soma Nutraceuticals, Inc. subsidiary for the acquisition and marketing of proven nutraceutical products, as well as acquisition discussions with multiple proven nutraceutical intellectual properties. Our Chairman Emeritus “Doc” Summers owns some of the proven nutraceutical products we Read more about AngioSoma, Inc. enters discussions with Nutraceutical Intellectual Property Owners[…]